C OSBORNE to Patient Selection
This is a "connection" page, showing publications C OSBORNE has written about Patient Selection.
Connection Strength
0.032
-
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol. 2010 Jan; 11(1):55-65.
Score: 0.013
-
Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185). Am J Clin Oncol. 2007 Apr; 30(2):113-25.
Score: 0.011
-
Spreading the word, but not too thinly. Lancet. 2004 Jan 10; 363(9403):165-6.
Score: 0.009